Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spleen Aminopeptide Oral Solution for Pediatric Allergic Rhinitis with Adenoid Hypertrophy
ChiCTR2200056763Phase 4Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Nov 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of spleen polypeptide in allergic rhinitis (AR) and adenoidal hypertrophy (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoints: A/N ratio of adenoid hypertrophy and Endoscopic evaluation. Started Nov 2021; status: completed.
02
Drugs
spleen polypeptide
03
Conditions
allergic rhinitis (AR)adenoidal hypertrophy
Beyond the preview
Go deeper on ChiCTR2200056763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056763.